ChemicalBook > CAS DataBase List > TocilizuMab
TocilizuMab
- Product Name
- TocilizuMab
- CAS No.
- 375823-41-9
- Chemical Name
- TocilizuMab
- Synonyms
- Actemra;Atlizumab;R 1569;RoActemra;TocilizuMab;Actemra 200;Tocilizumab-Actemra;Tocilizumab,Atlizumab;anti-IL-6R Tocilizumab;Tocilizumab (anti-IL-6R)
- CBNumber
- CB32735437
- Molecular Formula
- C14H12O3
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
TocilizuMab Property
- storage temp.
- Store at -80°C
- solubility
- Soluble in DMSO
- form
- Liquid
- color
- Colorless to light yellow
More
Less
N-Bromosuccinimide Price
American Custom Chemicals Corporation
- Product number
- ATB0023425
- Product name
- TOCILIZUMAB
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $503.02
- Updated
- 2021/12/16
Biosynth Carbosynth
- Product number
- BT165595
- Product name
- Tocilizumab
- Packaging
- 1mg
- Price
- $600
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0028521
- Product name
- Tocilizumab
- Purity
- 99.67%
- Packaging
- 5mg
- Price
- $670
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0028521
- Product name
- Tocilizumab
- Purity
- 99.67%
- Packaging
- 1mg
- Price
- $280
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0028521
- Product name
- Tocilizumab
- Purity
- 99.67%
- Packaging
- 25mg
- Price
- $2500
- Updated
- 2021/12/16
More
Less
TocilizuMab Chemical Properties,Usage,Production
Clinical Use
Interleukin inhibitor:
Treatment of rheumatoid arthritis in combination with methotrexate
Drug interactions
Potentially hazardous interactions with other drugs
Live vaccines: avoid concomitant administration
Metabolism
Tocilizumab undergoes biphasic elimination from the circulation. The total clearance of tocilizumab is concentration-dependent and is the sum of the linear and non-linear clearance. The concentration-dependent non-linear clearance plays a major role at low tocilizumab concentrations. Once the non-linear clearance pathway is saturated, at higher tocilizumab concentrations, clearance is mainly determined by the linear clearance.
TocilizuMab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
TocilizuMab Suppliers
- Tel
- 0576-84613060 13093829633
- Fax
- 0576-84613060
- sales@kedechemical.com
- Country
- China
- ProdList
- 298
- Advantage
- 60
- Tel
- 27-027-83314682 13554138826
- Fax
- +86 (27) 8331-4682
- whsrtech@vip.163.com
- Country
- China
- ProdList
- 230
- Advantage
- 62
- Tel
- 027-59207852 13308628970
- Fax
- QQ3130921841
- buy@fortunachem.com
- Country
- China
- ProdList
- 2866
- Advantage
- 58
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Country
- China
- ProdList
- 4727
- Advantage
- 58
- Tel
- 025-57798810
- Fax
- 025-57019371
- sales@sunlidabio.com
- Country
- China
- ProdList
- 3239
- Advantage
- 55
- Tel
- 0571-86403260 86403970
- Fax
- 0571-86403970
- lucky@lkbiology.com
- Country
- China
- ProdList
- 243
- Advantage
- 58
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4566
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9806
- Advantage
- 58
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8012
- Advantage
- 62
- Tel
- 010-60605840 18892239720
- Fax
- 010-60605840
- psaitong@jm-bio.com
- Country
- China
- ProdList
- 12306
- Advantage
- 58
More
Less
View Lastest Price from TocilizuMab manufacturers
WUHAN FORTUNA CHEMICAL CO., LTD
- Product
- Tocilizumab 375823-41-9
- Price
- US $0.00-0.00/g
- Min. Order
- 1g
- Purity
- 99%
- Supply Ability
- 100G
- Release date
- 2021-06-02
Hebei Weibang Biotechnology Co., Ltd
- Product
- TocilizuMab 375823-41-9
- Price
- US $10.00/KG
- Min. Order
- 100KG
- Purity
- 99%
- Supply Ability
- 100 mt
- Release date
- 2024-12-04
Wuhan Senwayer Century Chemical Co.,Ltd
- Product
- TocilizuMab 375823-41-9
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- 99%
- Supply Ability
- 50kg
- Release date
- 2023-02-08
375823-41-9, TocilizuMabRelated Search:
mepolizumab
Clazakizumab
Ieramilimab
Ritonavir
Lenalidomide
Rituximab
Rituximab
IGE, ANTI-HUMAN, GOAT, IGG FRAC, FITC, LQ
non A4 component of amyloid precursor, PARK1, PARK4, PD1, NACP (Non-a-beta component of Alzheimer disease amyloid, precursor)
Trastuzumab